Antidiabetic and hypolipidemic effects of adropinin streoptozotocin-induced type 2 diabetic rats.


BACKGROUND To examine the effects of adropin on glucose and lipid metabolism in a rat model of Type 2 diabetes mellitus (T2DM). METHODS T2DM were established using high-fat diet and streptozocin (STZ; 35 mg/kg/b.w.). Seven days after STZ induction, diabetic rats were randomly treated with adropin (2.1 μg/kg/day intraperitonealy) for 10 days. The study… (More)


4 Figures and Tables

Slides referencing similar topics